LIGAND PHARMACEUTICALS INC

By person

17 insiders · 356 transactions

78.4×

Todd C. Davis holds 78.4 times base salary in stock. $56.86M of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Todd C. Davis last reported holding, valued at $285.00, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

HIGGINS JOHN L

Director

$854.26K (4)

$55.17M (25) scheduled

−$54.31M

417,695

2.10%

$119.04M

+198.8%

Aryeh Jason

Director

$744.81K (12)

$25.42M (20)

−$24.68M

154,174

0.7734%

$43.94M

−49.6%

FOEHR MATTHEW W

Former Executive Officer

$206.91K (1)

$23.77M (14) scheduled

−$23.56M

162,187

0.8136%

$46.22M

+95.3%

Espinoza Octavio

Chief Financial Officer

$156.09K (2)

$15.27M (25) scheduled

−$15.12M

27,696

0.1389%

$7.89M

+124.8%

Berkman Charles S

Former Executive Officer

—

$12.57M (5)

−$12.57M

23,825

0.1195%

$6.79M

−37.2%

Korenberg Matthew E

President & COO

$43.09K (1)

$12.57M (15) scheduled

−$12.53M

50,777

0.2547%

$14.47M

+233.4%

Reardon Andrew

CLO & Secretary

—

$10.20M (61) scheduled

−$10.20M

36,514

0.1832%

$10.41M

+203.5%

Patel Sunil

Former Director

$178.50K (2)

$10.15M (1) scheduled

−$9.97M

28,820

0.1446%

$8.21M

−25.4%

Sabba Stephen L

Director

—

$6.76M (11) scheduled

−$6.76M

33,629

0.1687%

$9.58M

+20.3%

LAMATTINA JOHN L

Director

—

$6.25M (13) scheduled

−$6.25M

26,969

0.1353%

$7.69M

+28.4%

KOZARICH JOHN W

Director

—

$5.34M (58)

−$5.34M

42,622

0.2138%

$12.15M

+6.3%

Davis Todd C

Chief Executive Officer

$1.58M (6)

$6.49M (6)

−$4.92M

199,513

1.00%

$56.86M

+250.5%

Haas Jason

Director

—

$3.74M (3) scheduled

−$3.74M

3,981

0.0200%

$1.13M

+217.7%

Gray Nancy Ryan

Director

—

$1.43M (3) scheduled

−$1.43M

8,930

0.0448%

$2.55M

+1,142%

Zimmermann Martine

Director

—

$342.00K (1)

−$342.00K

3,897

0.0195%

$1.11M

—

Boyce Sarah

Former Director

—

2,892

0.0145%

$824.22K

—

Cochran Jennifer R.

Former Director

—

1,161

0.0058%

$330.89K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Espinoza Octavio

9 May 2025

Chief Financial Officer

Buy

500

$104.40

$52.20K

Espinoza Octavio

9 May 2025

Chief Financial Officer

Buy

1,000

$103.89

$103.89K

Davis Todd C

9 May 2025

Chief Executive Officer

Buy

5,523

$105.67

$583.63K

Davis Todd C

9 May 2025

Chief Executive Officer

Buy

2,307

$104.53

$241.15K

Davis Todd C

9 May 2025

Chief Executive Officer

Buy

1,680

$104.57

$175.68K

Davis Todd C

8 Aug 2024

Chief Executive Officer

Buy

2,500

$97.39

$243.48K

Davis Todd C

22 Sep 2023

CHIEF EXECUTIVE OFFICER

Buy

4,000

$59.38

$237.53K

FOEHR MATTHEW W

13 May 2022

President and COO

Buy

2,500

$82.76

$206.91K

Patel Sunil

2 Nov 2020

Director

Buy

1,000

$82.52

$82.52K

Korenberg Matthew E

3 Sep 2019

EVP,Finance & Strategy and CFO

Buy

500

$86.18

$43.09K

Showing 250 of 356 transactions. The figures above use every one of them.

LIGAND PHARMACEUTICALS INC

By person

Individual transactions

What was left out